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Objectives: To evaluate the predicative power of the electrical risk score (ERS), a noninvasive 
and inexpensive test obtained by means of a standard 12-lead electrocardiogram (ECG), 
in a cohort of elderly patients who had undergone transcatheter aortic valve replacement 
(TAVR).
Methods: Survivors and non-survivors after TAVR at 1-year follow-up were compared in 
respect to the pre-procedural ERS as well as a number of other clinical and instrumental vari-
ables. ERS is composed of seven simple ECG markers: heart rate (.75 bpm); QRS duration 
(.110 ms); left ventricular hypertrophy (Sokolow–Lyon criteria); delayed QRS transition zone 
($ V4); frontal QRS-T angle (.90°); long QT
Bazett
 (.450 ms for men and .460 in women) 
or JT
Bazett
 (330 ms for men and .340 ms for women); and long Tpeak to Tend interval (T
p-e
) 
(.89 ms). The trial was registered in ClinicalTrials.gov as NCT03145376.
Results: A total of 40 patients were evaluated. During the follow-up, the all-cause mortality 
rate was 25% (ten patients) with 15% of cardiovascular death (six patients). The ERS was the 
strongest predictor of all-cause (odds ratio 3.73, 95% CI: 1.44–9.66, P,0.05) or cardiovascular 
(odds ratio 3.95, 95% CI: 1.09–14.27, P,0.05) mortality. Receiver operating characteristic 
curves showed that ERS had the widest significant sensitivity-specificity area under the curve 
(AUC) predicting all-cause (AUC: 0.855, P,0.05) or cardiovascular mortality (AUC: 0.908, 
P,0.05).
Conclusion: ERS seems to be a useful noninvasive tool able to stratify the risk of mortality 
in 1-year follow-up of TAVR patients. These findings, however, require larger trials to be 
confirmed.
Keywords: aortic stenosis, transaortic valve replacement, electrical risk score, mortality, 
Tpeak–Tend, QTc, frontal QRS-T angle
Introduction
Symptomatic senile degenerative aortic stenosis (AS) leads to a progressive dete-
rioration of quality of life and it is associated with an elevated mortality.1 The most 
recent guidelines for the treatment of valvular heart disease identify the degenerative 
AS as the most common valve disease in Western countries, especially in the group 
aged over 65 years.2–5 In its most severe form, AS represents a highly debilitating 
chronic disease characterized by symptoms such as precordial pain suggestive of 
angina, transient altered state of consciousness, or syncope, dyspnea and other heart 
failure symptoms secondary to a reduced stroke volume. After the onset of symp-
toms, in the case of no valve replacement procedure, the survival is less 50% within 
the first 2 years.6,7 Given that the conventional thoracic surgical approach is usually 
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impossible in very elderly patients, transcatheter aortic 
valve replacement (TAVR) is often preferred even if this 
type of procedure suffers from a high perioperative risk.8 
Up to now, a multidisciplinary evaluation (interventional 
cardiologist and expert in cardiovascular imaging, geri-
atrician, anesthesiologist etc.) is usually required to assess 
the patient’s TAVR suitability.10,11 Indeed, the inclusion 
criteria for such a procedure are hemodynamic (mean aortic 
gradient, left ventricular ejection fraction, stroke volume 
index, etc.), anatomical (aortic valve and root morphology, 
etc.) and, obviously, clinical (symptoms, comorbidities, 
frailty, physical and cognitive functions, nutrition evalua-
tion). Furthermore, TAVR is considered futile, and hence 
contraindicated, in those cases where the life expectancy is 
lower than 1 year due to comorbidities, despite a successful 
procedure, or when a chance of “survival with benefit” is 
lower than 25% at 2 years.10,11 However, it remains often 
difficult to exclude a potential benefit and, consequently, to 
establish the TAVR futility in a great percentage of patients,9 
so that further implementation of the current strategies with 
additional variables is highly desirable. In such a context, 
the electrical risk score (ERS),12 an easy marker obtained 
from a standard 12-lead electrocardiogram (ECG), could 
represent a noninvasive and inexpensive useful clinical tool. 
Indeed, in senile AS, the prolonged systolic overload induced 
both anatomical and electrical remodeling13 and the major 
ECG findings associated with AS are also included in the 
ERS index (hypertrophy, intraventricular conduction delay, 
repolarization alterations). Aortic valve replacement can be 
associated with a reverse remodeling and more favorable 
outcome.
This actual retrospective study sought to investigate 
the possible utility of ERS in TAVR patients’ selection. 
Briefly, we hypothesized that an increased ERS could be 
able to help the physician in identifying those patients with 
irreversible ventricular damage14–17 and, accordingly, help 
to predict a poor survival and, hence, a TAVR futility. To 
verify this hypothesis, we calculated the pre-procedural ERS 
in a cohort of patients who underwent TAVR and collected 
the overall and cardiovascular mortality data after 1-year 
follow-up.
Methods and materials
Participants and protocol
A total of 42 consecutive symptomatic patients with AS were 
evaluated for TAVR at Policlinico Umberto I University 
Hospital between March 2015 and September 2016. 
At the time of the first evaluation, patients’ general data, 
a 12-lead ECG, a preoperative transthoracic Doppler 
echocardiographic evaluation (left ventricular telediastolic 
and telesistolic diameter, interventricular septum and 
posterior wall thickness, transvalvular aortic gradients/
regurgitation, aortic valve area, left ventricular ejection frac-
tion, and left ventricular mass), and a full clinical assessment 
were recorded. The latter also included the following: the 
Mini-Mental State Examination (MMSE) to screen possible 
cognitive impairment; the Cumulative Illness Rating Scale 
(CIRS) to evaluate patients’ comorbidities; the Activity of 
Daily Living (ADL) and Instrumental Activities of Daily 
Living (IADL) to evaluate the independence of the patients 
in everyday activities; the Mini-Nutritional Assessment 
(MNA) to estimate possible problems in the nutritional status; 
and the Short Form Health Survey-36 (SF-36) to assess the 
patient’s quality of life, adjusted for age and sex among the 
Italian population. Furthermore, the Clinical Frailty Scale 
(CSF) was calculated to assess the impairment of patients in 
a scale from 1 (very fit) to 9 (terminally), considering data 
from the whole geriatric evaluation previously performed.18 
Exclusion criteria for TAVR was a moderate-to-severe frailty 
score ($6).11
The endpoint, retrospectively analyzed, was the all-
cause and cardiovascular mortality at 1 year. The study was 
approved by the Ethical Committee of Azienda Universitaria 
Policlinico Umberto I. All participants provided their written 
informed consent. The trial was registered in ClinicalTrials.
gov as NCT03145376.
electrocardiographic analysis
Each enrolled patient had a stored resting 12-lead ECG 
(Esaote, model: MyCardioPad/XL 12 channels, Florence, 
Italy) available for the analysis (paper speed was 25 mm/s 
and calibration 10 mm/mV). Those patients with ECG 
evidence of atrial flutter or II/III-degree atrioventricular 
block, pre-excitation, or paced rhythm were excluded from 
analysis.
Heart rate, QRS duration, left ventricular hypertrophy 
(Sokolow–Lyon criteria), delayed QRS transition zone, 
frontal QRS-T angle, long QT
Bazett
 or JT
Bazett
, and long 
Tpeak to Tend interval (T
p-e
) compose the ERS.11 In this 
score 1 and 0 were assigned respectively for an abnor-
mal or normal ECG electrical value, and a score $4 was 
considered predictive of high risk for mortality.12 Abnor-
mal ECG data were considered as the following: a heart 
rate .75 bpm, QRS duration .110 ms, the left ventricular 
hypertrophy, achieved with the Sokolow–Lyon criteria, 
the QRS transition $ 4th precordial lead (V4), the frontal 
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QRS-angle .90°, and T
p-e
 .89 ms.12 Frontal QRS-T angle 
was calculated as the difference between T wave and QRS 
axis; in case the difference between QRS and T axis was 
higher than 180°, QRT-T angle was calculated by subtracting 
these achieved degrees from 360°.19 Moreover, with regard to 
repolarization phase, we used the QT for QRS ,120 ms and 
JT for QRS for .120 ms.20,21 In both cases we corrected these 
two intervals by the Bazett method (QT
Bazett
: QT/RR0.5 and 
JT
Bazett
: JT/RR0.5). Respectively, a QT
Bazett
 interval .450 ms 
for men and .460 ms for women, a JT
Bazett
, a value .330 ms 
for men and .340 ms for women were considered prolonged 
and then a risk factor for mortality.22,23 An expert cardiologist 
analyzed all ECGs in our electrocardiographic laboratory cal-
culating the ERS for each patient in a pre-procedural ECG.
statistical analysis
We compared the baseline study data obtained before 
TAVR between the dead and surviving patients after 1-year 
follow-up. Normally distributed continuous variables are 
reported as mean and standard deviation and are compared 
using Student’s t-test with Levene’s test for homogeneity of 
variance. Non-normally distributed variables are expressed 
as median and inter-quartile range (IQR) and compared 
using the Mann–Whitney U test. Categorical variables are 
presented as frequencies and percentage and compared using 
the chi-squared test. Receiver operating characteristic (ROC) 
curves were used to determine the sensitivity and specificity 
of the studied parameters predictive of all-cause and cardio-
vascular mortality, and areas under ROC curves and 95% 
confidence intervals (CI) were calculated to compare the 
diagnostic efficiencies.
Uni- and multivariable forward (Wald) stepwise logistic 
regression analysis were used to determine the association 
between all-cause mortality or cardiovascular mortality and 
the other selected clinical, functional, echocardiographic, and 
electrical covariates included in the study model. Included 
covariates were: age, gender, body mass index, blood pres-
sure, New York Heart Association (NYHA) class, MMSE, 
CIRS ADL, IADL, MNA, SF-36, aortic peak gradient, aortic 
mean gradient, ejection fraction, stroke volume index, cardiac 
index, left ventricular mass index, heart rate, QRS, QTc, JT
C
, 
T
p-e
, QRS-T angle, QRS transition zone, electrocardiography 
left ventricular hypertrophy, and ERS.
Results
Forty-two patients underwent a complete evaluation; two 
patients were excluded from the TAVR procedure due to 
high level of comorbidities (Frailty score $6).
Of the 40 patients included in the study, within the first 
year of follow-up, a total of 10 patients died (overall mortality 
rate 25%). Specifically, six patients died from cardiovascu-
lar diseases (CVDs; two from heart failure worsening and 
four from stroke) (mortality rate 15%), and four patients 
died for non-CVDs (three patients for respiratory infec-
tions and one for malignancy) (mortality rate 10%). At the 
time of presentation, all patients were in III or IV NYHA 
functional class (Figure 1). Clinical and demographic char-
acteristics are reported in Table 1, together with the type of 
valve implanted. In the pre-procedural evaluation, most of 
the clinical characteristics, functional assessment, and drug 
therapy were similar between survivors and non-survivors. 
Nevertheless, the survivors showed a significantly higher 
level of left ventricular ejection fraction, cardiac, and stroke 
volume indexes with regard to the subjects who died from 
cardiovascular issues (ejection fraction: 51±8 vs 37% ± 3%, 
P,0.001; cardiac index: 2.2±0.3 vs 1.9±0.3 L/m2, P,0.05; 
stroke volume index: 33±5 vs 27±5 mL/m2, P,0.05) and 
of all-cause mortality (survivors vs deceased patients, ejec-
tion fraction: 51±8 vs 38% ± 5%, P,0.001; cardiac index: 
2.2±0.3 vs 1.7±0.4 L/m2, P,0.05; stroke volume index: 
33±5 vs 27±4 mL/m2, P,0.05). The survivors showed a 
significantly lower level of peripheral resistances in com-
parison with the deceased patients from CVDs (survivors 
vs deceased patients: peripheral resistances: 1,983±561 
vs 2,650±612 arbitrary units, P,0.05) and for all-cause 
mortality (survivors vs deceased patients: peripheral resis-
tances: 1,983±561 vs 2,723±544 arbitrary units, P,0.05). 
We did not find any differences between subjects for other 
echocardiographic data.
Regarding the ECG data (Table 2), the survivors showed 
lower electrical noninvasive parameters than the deceased 
subjects for cardiovascular or non-cardiovascular causes 
(Table 3). Particularly, in comparison with the deceased 
subjects for CVDs, the survivors reported a significant 
lower level of: T
p-e
 (survivors vs deceased patients: 89±20 
vs 117±7 ms, P,0.05), QRS transition zone (survivors vs 
deceased patients: V4 ±1 vs V5 ±2, P,0.05), QRS-T angle 
(survivors vs deceased patients: -111, IQR 181 vs 96, IQR 
228°, P,0.05), electrocardiogram left ventricular hyper-
trophy (survivors vs deceased patients: 2±1 vs 3±1 mV, 
P,0.05), and whole ERS (survivors vs CVD patients: 2±1 vs 
5±2 score, P,0.001) (Figure 1). We pointed out almost the 
same pattern for the deceased subjects for all-cause mortality. 
Specifically, survivors had lower levels of: T
p-e
 (survivors 
vs deceased patients: 89±20 vs 110±11 ms, P,0.05), QRS 
transition zone (survivors vs deceased patients: V4 ±1 vs 
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V5 ±2, P,0.05), electrocardiogram left ventricular hyper-
trophy (survivors vs deceased patients: 2±1 vs 3±1 mV, 
P,0.05), and ERS (survivors vs deceased patients: 2±1 vs 
4±2 score, P,0.001) (Figure 2). All survivors had an ERS 
value lower than 4, both considering the cardiovascular and 
non-cardiovascular mortality (Figure 3A and B).
The ERS variable showed the ROC curves with the 
highest sensitivity/specificity both for all-cause (AUC: 0.855, 
Figure 1 Comparison between survivors and cardiovascular mortality cases regarding the significant ECG data, obtained baseline.
Notes: In particular, the survivor subjects after 1 year of TAVr follow-up showed lower pre-TAVr: Tpeak–Tend segment, Qrs transition zone, Qrs-T angle, eCg left 
ventricular hypertrophy, and ers. In the box plots, the central line represents the median distribution. each box spans from 25th to 75th percentile points, and error bars 
extended from 10th to 90th percentile points.
Abbreviations: eCg, electrocardiogram; ers, electrical risk score; TAVr, transcatheter aortic valve replacement; V4, 4th precordial lead.
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P,0.05) and cardiovascular mortality (AUC: 0.908, P,0.05) 
(Figure 4A and B). Other variables with statistical signifi-
cance were T
p-e
 (P,0.05), QRS transition zone (P,0.05), 
electrocardiography left ventricular hypertrophy (P,0.05) 
for the all-cause mortality (Figure 4A) and all these electrical 
parameters and QTc (P,0.05) and QRS-T angle (P,0.05) 
for the cardiovascular mortality, too (Figure 4B). Hemody-
namic variables reported extremely low accuracy values for 
all-cause or cardiovascular mortality; aortic valve gradients 
or left ventricular mass index (LVMI) AUC did not report 
any statistical significance.
Univariable logistic regression analysis reported a 
significant relationship between all-cause mortality and 
ERS (P,0.05), ejection fraction (P,0.05), ECG hyper-
trophy (P,0.05), QRS transition zone (P,0.05), T
p-e
 
(P,0.05) (Figure 5) and between cardiovascular mortality 
and ERS (P,0.05) and ejection fraction (P,0.05) (Figure 5). 
Multivariable logistic regression analysis only selected ERS 
as the significant risk factor for all-cause (odds ratio 3.73, 
95% CI: 1.44–9.66, P,0.05) or cardiovascular mortality 
(odds ratio 3.95, 95% CI: 1.09–14.27, P,0.05) (Figure 5).
Discussion
The most important finding of our study was that a simple 
and almost inexpensive score obtained from the standard 
12-lead electrocardiogram is significantly higher in TAVR 
subjects with high risk of mortality at 1-year follow-up. Thus, 
we could reasonably consider the ERS as a useful tool in 
managing TAVR patients’ selection. In particular, our data 
Table 1 general characteristics of the transcatheter aortic valve 
replacement patients
Analyzed data N: 40
Age, years 81±7
M/F 23/17
BMI, kg/m2 26±4
sBP, mmhg 135±13
DBP, mmhg 84±56
Atrial fibrillation 25 (63)
Complete left bundle branch block 15 (38)
nYhA class III 38 (95)
nYhA class IV 2 (5)
Aortic peak gradient, mmhg 82±20
Aortic mean gradient, mmhg 52±13
ejection fraction, % 48±10
stroke volume index, ml/m2 31±6
Cardiac index, l/m2 2.05±0.36
Peripheral resistance, units 2,168±639
left ventricular mass index, g/m2 141±31
Mini-mental state evaluation 26±3
Cumulative illness rating scale 12±4
Activity of day living 5±1
Instrumental activities of day living 5±2
Clinical frailty scale 4±1
Mini-nutritional assessment 23±4
short form health survey
– Vitality 45±14
– Physical functioning 21±19
– Body pain 58±29
– general heath perceptions 44±17
– Physical role functioning 14±31
– emotional role functioning 38±46
– social role function 45±18
– Mental health 58±15
β-blockers, n (%) 35 (88)
Furosemide, n (%) 24 (60)
Calcium channel blockers, n (%) 16 (40)
ACe/sartan, n (%) 13 (63)
Amiodarone, n (%) 2 (5)
Anticoagulants, n (%)
Valve type
25 (63)
•	 CoreValve, n (%)
•	 edwardsXT, n (%)
•	 edwards sapien 3, n (%)
•	 CoreValveevolut r, n (%)
•	 Direct Flow, n (%)
•	 lotus, n (%)
2 (5%)
1 (2.5%)
19 (47.5%)
12 (30%)
5 (12.5%)
2 (5%)
Note: Data are expressed as mean ± sD or number (n) of patients (%).
Abbreviations: ACe, angiotensin-converting enzyme; BMI, body mass index; DBP, 
diastolic blood pressure; M/F, male/female; nYhA, new York heart Association; 
sBP, systolic blood pressure.
Table 2 electrocardiographic measures in the transcatheter 
aortic valve replacement patients
Analyzed data N: 40
heart rate, bpm 74±13
Qrs, ms 115±25
QTC, ms 460±46
JTC, ms 334±44
Tpeak–Tend, ms 94±20
Qrs-T angle, ° -60 (118)
Qrs transition zone 4±1
electrocardiographic left ventricular  
hypertrophy, mV
3.4±1.4
electrical risk score 3.9±1.9
Note: Data are expressed as mean ± sD or median (interquartile range).
Table 3 electrocardiographic abnormal markers in the tran-
scatheter aortic valve replacement patients
Analyzed data N: 40
heart rate .75 15 (38)
Qrs .110 ms 20 (50)
QTBazett .450 or .460 ms or JTBazett .330 or .340 ms 21 (53)
Tpeak–Tend .89 ms 23 (58)
Qrs-T angle .90° 12 (30)
Qrs transition zone $ V4 15 (38)
electrocardiographic left ventricular hypertrophy 10 (25)
electrical risk score $4 5 (13)
Notes: Data are presented as cases (%), QTc .450 ms in men and .460 ms in 
women; JTBazett .330 in men or .340 ms in women.
Abbreviation: V4, 4th precordial lead.
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show that all surviving patients had an ERS value below 4 
while half of the patients who died showed an ERS equal 
or higher than 4. The ROC curves showed that the ERS had 
the widest significant sensitivity-specificity AUC predicting 
all-cause or cardiovascular mortality and, even, the multivari-
able forward stepwise logistic regression analysis selected 
the ERS as the most significant risk factor of the all-cause or 
cardiovascular mortality and it excluded the ejection fraction 
or stroke volume index as risk factors, which are the usual 
markers with the more reliable level of predictively.14–17
The ERS is composed of seven different electrocardio-
graphic markers, each of them an expression of electrical 
and structural cardiac damage. In such context, it is likely 
that the noninvasive ECG variables are earlier markers 
of mortality risk given that they depend on imbalanced 
neuro-autonomic control (heart rate, QTc, and T
p-e
), on the 
repolarization alterations (QTc, QRS-angle, and T
p-e
) and on 
cardiac hypertrophy (QTc, QRS-angle, QRS transition, and 
T
p-e
), all of them known markers of poor outcome in chronic 
heart failure and coronary artery disease.
Between the seven noninvasive ECG markers, included in 
the ERS, heart rate is the simplest and apparently trivial. We 
can consider heart rate with a double clinical meaning: firstly 
as a mere index of heart failure decompensation and secondly 
as an instantaneous marker of autonomic cardiovascular con-
trol. Indeed, in AS patients the sympathetic control prevails on 
the vagal and baroreceptor activity thus leading to an increase 
of heart rate, of myocardial oxygen demand, and relative 
ischemia with a tendency to ventricular and supraventricular 
arrhythmias. A great number of observations indicates that the 
increase of resting heart rate was an important risk factor for 
mortality in the chronic heart failure.24–26 In contrast, the QTc 
or JTc, and T
p-e
 are markers of ventricular repolarization delay 
and ventricular arrhythmia tendency. In particular, prolonged 
Figure 2 Comparison between survivors and total mortality cases regarding the significant ECG data, obtained baseline.
Notes: In particular, the survivor subjects after 1 year of TAVR follow-up showed a significant lower pre-TAVR: Tpeak–Tend segment, QRS transition zone, electrocardiogram 
left ventricular hypertrophy, and ers. In the box plots, the central line represents the median distribution. each box spans from 25 to 75th percentile points, and error bars 
extended from 10 to 90th percentile points.
Abbreviations: eCg, electrocardiogram; ers, electrical risk score; TAVr, transcatheter aortic valve replacement.
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Figure 3 We reported the total (A) and cardiovascular (B) mortality in the subjects with less or equal or higher than four electrical risk score in the study subjects.
Notes: In the B study population, we excluded the subject deceased for non-CVD. statistical comparison was obtained by chi-squared test.
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Figure 4 receiver operating characteristic curve (rOC) analysis showing that the electrical risk score (ers) was the best predictor of total (A) or cardiovascular (B) 
mortality in TAVr patients.
Abbreviations: sig, significance; std, standard; TAVR, transcatheter aortic valve replacement.
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QTc and T
p-e
 express an excessive length of the action’s 
potential duration, the ventricular damage, and loss of ionic 
channel controls. Moreover, the cardiac hypertrophy and heart 
failure induce an abnormal potassium channel function and a 
reduction of the repolarization reserve.27 On the other hand, 
although controversial,28,29 T
p-e
 is thought to be associated 
with the apico-basal and transmural action potential dura-
tion gradients30 and influenced by autonomic nervous system 
in several CVD settings.31–33 Both QTc and T
p-e
 increase in 
cases of cardiac hypertrophy, ischemia, and heart failure, and 
they represent known risk factors of all-cause cardiovascu-
lar mortality.34–39 In particular, a relationship was observed 
between outcome and QTc in severe AS with low flow, low 
gradient, reduced ejection fraction, and mortality.40 Obvi-
ously, the QTc measurement does not make any sense in the 
presence of complete left bundle branch block and, in such 
a case, the use of the JTc interval is more appropriate.20,21,41 
The QRS duration, the transition QRS zone, the electrical 
left ventricular hypertrophy, and the frontal QRS-T angle 
are influenced by myocardial mass and fibrosis. Particularly, 
the QRS duration, a marker of intraventricular conduction, 
was independently related to all-cause mortality,42 especially 
in patients with severe AS and low flow, low gradient and 
reduced ejection fraction.43 In our study, half of the subjects 
reported an increase of QRS duration, more than 110 ms, a 
cutoff assigned in the original paper by Aro et al on ERS.12 The 
transition zone at V4 or leftward of V4 on chest, otherwise 
known as the clockwise rotation (Minnesota code: 9-4-2)44 
was recently associated with an increase of all-cause45,46 or 
cardiovascular mortality45 or to a heart failure46 in subjects 
apparently free from CVD. Another study reported that the 
delayed transition zone was related to the left ventricular mass 
and that this electrical marker, independently from the left 
ventricular ejection fraction, was a risk predictor of sudden 
cardiac death.12 In our study, 38% of subjects showed the 
delayed transitional zone. In a paper dealing with this elec-
trical marker, authors preferred to exclude the subjects with 
left or right bundle branch block, because in their study the 
intraventricular block could be considered a confounding fac-
tor. In that study, the authors analyzed the possible predictive 
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Figure 5 Odds ratio for electrical risk score, electrocardiographic left ventricular hypertrophy (eCg lVh), Qrs transition zone $ V4, Tpeak–Tend interval, ejection fraction 
in respect to total and cardiovascular mortality in uni- or multivariable analysis.
Abbreviation: V4, 4th precordial lead.
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role of the different QRS transition zones (counterclockwise, 
clockwise and no rotation) on mortality.46 Subjects with 
counterclockwise rotation showed a lower risk of mortality; 
obviously in subjects with the right bundle branch block, 
we can always observe counterclockwise rotation, with a 
deep S in V2 and therefore that electrocardiographic picture 
could be interpreted as a favorable condition (false negative). 
To exclude possible false negative results, the authors decided 
not to include all intraventricular conduction disturbances. 
In contrast, in our study we observed only subjects with left 
bundle branch block (38%) and clockwise rotation. Another 
marker, most likely the most popular one, included in the ERS 
is the left ventricular Sokolow–Lyon voltage criteria. It is a 
weak maker of left hypertrophy degree,47 but it is indepen-
dently associated with the severity of valvulopathy48 and it is 
predictive of poor prognosis in patients with asymptomatic 
AS.49 Lastly, the frontal QRS-T angle higher than 90°, a mea-
sure of both depolarization and repolarization disturbance, 
was studied in populations with various risk patterns of car-
diovascular or all-cause mortality,50,51 but not particularly in 
AS elderly patients. However, the pressure overload,51,52 the 
left ventricular hypertrophy,53 and aging54 were reported as 
the most important causes of this electrical marker increase. 
Obviously, for this reason our data detected an increase of 
this marker in the AS in 30% of subjects.
In conclusion, the power of the ERS was not only a 
simple sum of different electrocardiographic markers, but 
it could be an inexpensive multilevel cardiac diagnostic 
tool capable of investigating the myocardial damage in the 
degenerative AS.
Study limitations
The small number of patients enrolled together with the 
low number of events represent an obvious limitation that 
allows us to suggest, rather than to affirm, that the ERS might 
improve the TAVR patients’ selection. Larger studies would 
be strongly encouraged to confirm our pilot observations.
Other possible limitation that should be acknowledged 
refers to Bazett’s formula for QT correction. Indeed, although 
routinely used in clinical practice, it overcorrects at elevated 
heart rates and under corrects at heart rates below 60 beats 
per minute (bpm) and hence is not an ideal correction. 
Fridericia’s correction is more accurate than Bazett’s cor-
rection in subjects with such altered heart rates. However, 
it should be highlighted that all patients evaluated in the 
present study had a heart rate between 60 and 90 bpm. 
Finally, other well-known electrical risk abnormalities (such 
as P wave duration, deep terminal negativity of the P wave, 
QRS fragmentation, ST segment depression and elevation, 
inverted T waves, T wave alternans, premature ventricular 
contractions) were not evaluated in the present study.
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